{"SLR NAME":"A rapid review of Echinacea for the prevention or treatment of COVID-19 and other respiratory tract infections in humans","References":[{"title1":"Effects of echinacea on the frequency of upper respiratory tract symptoms: a randomized, double-blind, placebo-controlled trial","References":[{"title2":"Zinc gluconate lozenges for treating the common cold: a randomized, double-blind, placebo-controlled study","References":[]},{"title2":"Rhinovirus infections in an industrial population, I: the occurrence of illness","References":[]},{"title2":"The American coneflower: a prophylactic role involving nonspecific immunity","References":[]},{"title2":"Efficacy and mode of action of an immunomodulator herbal preparation containing Echinacea, wild indigo, and white cedar","References":[]},{"title2":"Use of echinacea in medicine","References":[]},{"title2":"Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea","References":[]},{"title2":"Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to test subjects mediates activation of the phagocyte system","References":[]},{"title2":"Results of five randomized studies on the immunomodulatory activity of preparations of Echinacea","References":[]},{"title2":"A proprietary extract from the echinacea plant (Echinacea purpurea) enhances systemic immune response during a common cold","References":[]},{"title2":"Evaluation of echinacea for treatment of the common cold","References":[{"title3":"The common cold, health matters fact sheets"},{"title3":"The common cold"},{"title3":"Evaluation of echinacea for treatment of the common cold"},{"title3":"Treatment of the common cold with echinacea: a structured review"},{"title3":"The safety of herbal medicinal products derived from Echinacea species"},{"title3":"The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots"},{"title3":"Echinacea angustifolia: natural health products directorate. Draft January, 2004"},{"title3":"Echinacea purpurea: natural health products directorate. Draft January 19, 2004"},{"title3":"Echinacea pallida: natural health products directorate. Draft January 19, 2004"},{"title3":"Echinacea for preventing and treating the common cold"},{"title3":"An evaluation of Echinacea angustifolia in experimental rhinovirus infections"},{"title3":"Echinacea root extract for the prevention of upper respiratory tract infections: A double-blind, placebo-controlled randomized trial"},{"title3":"Therapeutic experiences with Echinacea pallida in influenzal infections"},{"title3":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?"},{"title3":"Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events"},{"title3":"Treatment of the common cold with unrefined echinacea. A randomized, double-blind, placebo controlled trial"},{"title3":"Echinacea and truth in labeling"},{"title3":"Echinacea purpurea for prevention of experimental rhinovirus colds"},{"title3":"Efficacy of Echinacea purpurea in patients with a common cold: a placebo-controlled, randomised, double-blind clinical trial"},{"title3":"A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections"},{"title3":"Influence of echinacin (EC31) treatment on the exercise-induced immune response in athletes"},{"title3":"Echinaguard treatment shortens the course of the common cold: a double-blind, placebo-controlled clinical trial"},{"title3":"Effectiveness of an herbal preparation containing echinacea, propolis and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study"},{"title3":"The efficacy of echinacea compound herbal tea preparation on the severity and duration of upper respiratory and flu symptoms: a randomized, double-blind placebo-controlled study"},{"title3":"Efficacy in the treatment of the common cold of a preparation containing an echinacea extract"},{"title3":"Ineffectiveness of echinacea for prevention of experimental rhinovirus colds"},{"title3":"Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial"},{"title3":"Use of echinacea in upper respiratory tract infection"},{"title3":"Vitamin C supplementation and respiratory infections: a systematic review"},{"title3":"Review of the biological properties and toxicity of bee propolis"},{"title3":"Echinacea angustifolia in rhinovirus infections"},{"title3":"Echinacea for preventing and treating the common cold"},{"title3":"Echinacea for the common cold"},{"title3":"An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures"}]},{"title2":"Toxicity of Echinacea purpurea: acute, subacute and genotoxicity studies","References":[]},{"title2":"Can herbal products be used safely during pregnancy? focus on echinacea","References":[]},{"title2":"The risk-benefit profile of commonly used herbal therapies: ginkgo, St. John's wort, ginseng, echinacea, saw palmetto, and kava","References":[]},{"title2":"Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial","References":[]},{"title2":"The efficacy of echinacea compound herbal tea preparation on the severity and duration of upper respiratory and flu symptoms: a randomized, double-blind placebo-controlled study","References":[]},{"title2":"Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo controlled, multicentre study","References":[]},{"title2":"Ineffectiveness of echinacea for prevention of experimental rhinovirus colds","References":[]},{"title2":"Efficacy of Echinacea purpurea in patients with a common cold: a placebo-controlled, randomised, double-blind clinical trial","References":[]},{"title2":"A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections","References":[]},{"title2":"Echinacea for prevention and treatment of upper respiratory infections","References":[]},{"title2":"Echinacea purpurea for prevention of upper respiratory tract infections in children","References":[]},{"title2":"Treatment of the common cold with unrefined Echinacea: a randomized, double-blind, placebo-controlled trial","References":[]},{"title2":"Efficacy of a standardized echinacea preparation (Echinilin) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trial","References":[]},{"title2":"Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial","References":[]},{"title2":"Echinacea purpurea for prevention of experimental rhinovirus colds","References":[]},{"title2":"Echinacea for preventing and treating the common cold","References":[{"title3":"Medicinal properties of Echinacea: a critical review"},{"title3":"Echinacea for preventing and treating the common cold"},{"title3":"Cough and the common cold: ACCP evidence-based clinical practice guidelines"},{"title3":"Treatment guidelines for upper respiratory tract infections"},{"title3":"Clinical knowledge summaries: common cold"}]},{"title2":"Echinacea in the prevention of induced rhinovirus colds: a meta-analysis","References":[]},{"title2":"The methodological quality of randomized controlled trials of homeopathy, herbal medicines and acupuncture","References":[]},{"title2":"Use of herbal remedies by patients in a health maintenance organization","References":[]},{"title2":"Inclusion of patients in clinical trial analysis: the intention-to-treat principle","References":[]}]},{"title1":"Safety and Efficacy Profile of <italic>Echinacea purpurea</italic> to Prevent Common Cold Episodes: A Randomized, Double-Blind, Placebo-Controlled Trial","References":[{"title2":"Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity","References":[]},{"title2":"Cromolyns: treatment fo the common cold?","References":[]},{"title2":"The economic burden of non-influenza-related viral respiratory tract infection in the United States","References":[]},{"title2":"Individual and community impact of influenza","References":[]},{"title2":"The common cold: a review of the literature","References":[]},{"title2":"Picornavirus infections: a primer for the practitioner","References":[]},{"title2":"Problems and prospects of developing effective therapy for common cold viruses","References":[]},{"title2":"The host response, not the virus, causes the symptoms of the common cold","References":[]},{"title2":"Antivirals for the common cold","References":[]},{"title2":"Biology of immune responses to vaccines in elderly persons","References":[]},{"title2":"The aging of the immune system","References":[{"title3":"Osteoimmunology: a current update of the interplay between bone and the immune system"},{"title3":"The impact of immune response on endochondral bone regeneration"},{"title3":"The immune privilege of the intervertebral disc: implications for intervertebral disc degeneration treatment"},{"title3":"Regulation of muscle growth and regeneration by the immune system"},{"title3":"The role of the immune cells in fracture healing"},{"title3":"Innate and adaptive immune system cells implicated in tendon healing and disease"},{"title3":"Role of inflammation and the immune system in the progression of osteoarthritis"},{"title3":"The role of the immune microenvironment in bone, cartilage, and soft tissue regeneration: from mechanism to therapeutic opportunity"},{"title3":"The involvement of immune system in intervertebral disc herniation and degeneration"},{"title3":"Musculoskeletal health"},{"title3":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019"},{"title3":"Global burden of musculoskeletal disorders and attributable factors in 204 countries and territories: a secondary analysis of the global burden of disease 2019 study"},{"title3":"The world-wide burden of musculoskeletal diseases: a systematic analysis of the world health organization burden of diseases database"},{"title3":"Osteoarthritis: a disease of the joint as an organ"},{"title3":"Osteoarthritis"},{"title3":"Synovitis in osteoarthritis: current understanding with therapeutic implications"},{"title3":"Regulation of immune responses and chronic inflammation by fibroblast-like synoviocytes"}]},{"title2":"Assessment of the clinical value of using an immunomodulator in recurrent respiratory infections","References":[]},{"title2":"Medicinal properties of Echinacea: a critical review","References":[]},{"title2":"The influence of the immunostimulating effects of pressed juice from Echinacea purpurea on the course and severity of cold infections","References":[]},{"title2":"Pflanzliches Immunstimulans senkt Haufigkeit grippaler Infekte","References":[]},{"title2":"Effectiveness of an herbal preparation containing Echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study","References":[]},{"title2":" Echinacea root extracts for the prevention of upper Respiratory tract Infections: a double-blind, placebo-controlled randomized trial","References":[]},{"title2":" Echinacea purpurea for prevention of experimental rhinovirus colds","References":[]},{"title2":"Ineffectiveness of Echinacea for prevention of experimental rhinovirus colds","References":[]},{"title2":"An evaluation of Echinacea angustifolia in experimental rhinovirus infections","References":[]},{"title2":" Echinacea in the prevention of induced rhinovirus colds: a meta-analysis","References":[]},{"title2":"A scale for assessing the severity of diseases and adverse drug reactions. Application to drug benefit and risk","References":[]},{"title2":"Sufficiently important difference for common cold: severity reduction","References":[]},{"title2":"Clinical significance of common cold treatment: professionals' opinions","References":[]},{"title2":"Randomised, double blind, placebo-controlled trial of Echinacea supplementation in air travellers","References":[{"title3":"Medical issues associated with commercial flights"},{"title3":"Changes in ocular and nasal signs and symptons among air crew in relation to air humidification on intercontinental flights"},{"title3":"Allergic rhinitis and ear pain in flight"},{"title3":"Spectrum of viruses and atypical bacteria in intercontinental air travelers with symptoms of acute respiratory infection"},{"title3":"Risks of travel, benefits of a specialist consult"},{"title3":"Clinical effects of rhinovirus infections"},{"title3":"Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease"},{"title3":"Perception of cabin air quality in airline crew related to air humidification, on intercontinental flights"},{"title3":"Complementary and alternative medicine use in Australia: a national population-based survey"},{"title3":"Complementary and alternative medicine use in Canada and the United States"},{"title3":"ABC of complementary medicine: users and practitioners of complementary medicine"},{"title3":"Echinacea increases arginase activity and has anti-inflammatory properties in RAW 264.7 macrophage cells, indicative of alternative macrophage activation"},{"title3":"Echinacea as an antiinflammatory agent: the influence of physiologically relevant parameters"},{"title3":"Antiviral activity of characterized extracts from Echinacea spp. (Heliantheae: Asteraceae) against Herpes simplex virus (HSV-I)"},{"title3":"Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract"},{"title3":"Enhancement of innate and adaptive immune functions by multiple Echinacea species"},{"title3":"Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects"},{"title3":"Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis"},{"title3":"Echinacea for preventing and treating the common cold"},{"title3":"Echinacea for preventing and treating the common cold"},{"title3":"Echinacea for treating the common cold a randomized trial"},{"title3":"Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties"},{"title3":"Echinacea intake induces an immune response through altered expression of leucocyte hsp70, increased white cell counts and improved erythrocyte antioxidant defences"},{"title3":"Pharmacokinetics of the main alkamides after administration of three different Echinacea purpurea preparations in humans"},{"title3":"Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion"},{"title3":"Echinacea alkylamides inhibit interleukin-2 production by Jurkat T cells"},{"title3":"A standardized echinacea extract demonstrates efficacy in the prevention and treatment of colds in athletes"},{"title3":"Echinacea in the prevention of induced rhinovirus colds: a meta-analysis"},{"title3":"Echinacea for prevention of the common cold: an illustrative overview of how information from different systematic reviews is summarised on the internet"},{"title3":"Comparison of Echinacea alkylamide pharmacokinetics between liquid and tablet preparations"},{"title3":"The Wisconsin Upper Respiratory symptom survey (WURSS): a new research instrument for assessing the common cold"},{"title3":"The Wisconsin Upper Respiratory Symptom Survey is responsive, reliable, and valid"},{"title3":"Relations among questionnaire and laboratory measures of rhinovirus infection"},{"title3":"How should the minimum important difference for a health-related quality-of-life instrument be estimated?"},{"title3":"Air travel and respiratory disease: proper assessment and preparation reduce the risk, but it pays to shop around"},{"title3":"Respiratory infections during air travel"},{"title3":"Lack of herbal supplement characterization in published randomized controlled trials"},{"title3":"Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: efficacy and safety"},{"title3":"The effect of Echinacea on upper respiratory infection symptom severity and quality of life"},{"title3":"The safety of herbal medicinal products derived from Echinacea species: a systematic review"}]},{"title2":"Community herbal monograph on Echinacea purpurea (L.) moench, herba recens","References":[]},{"title2":"Rhinoviruses and cells: molecular aspects","References":[]},{"title2":"Treatment of the common cold with Echinacea: a structured review","References":[]},{"title2":"Over-the-counter cold medications: a critical review of clinical trials between 1950 and 1991","References":[]},{"title2":"Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract","References":[]},{"title2":"Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian Influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV)","References":[{"title3":"On the epidemiology of influenza"},{"title3":"Novel swine-origin influenza A virus in humans: another pandemic knocking at the door"},{"title3":"Emergence and pandemic potential of swine-origin H1N1 influenza virus"},{"title3":"Avian influenza: The tip of the iceberg"},{"title3":"The Highly Pathogenic Avian Influenza H5N1-Initial Molecular Signals for the Next Influenza Pandemic"},{"title3":"Developing New Antiviral Agents for Influenza Treatment: What does the Future Hold?"},{"title3":"Inactivated influenza vaccines: methods, policies, and politics"},{"title3":"The potential impact of neuraminidase inhibitor resistant influenza"},{"title3":"Oseltamivir- and Amantadine-Resistant Influenza viruses A (H1N1)"},{"title3":"Influenza-virus-induced signaling cascades: targets for antiviral therapy?"},{"title3":"Targeting cell signaling pathways to fight the flu: towards a paradigm change in anti-influenza therapy"},{"title3":"Influenza virus propagation is impaired upon specific inhibition of the Raf/MEK/ERK signaling cascade"},{"title3":"MEK inhibition impairs influenza B virus propagation without emergence of resistant variants"},{"title3":"NF-kappaB-dependent of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation"},{"title3":"Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity"},{"title3":"Inhibition of Influenza Virus Replication by Resveratrol"},{"title3":"Anti-influenza Agents from Plants and Traditional Chinese Medicine"},{"title3":"A Polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance"},{"title3":"CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice"},{"title3":"Phytomedicines as antivirals"},{"title3":"Induction of pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract"},{"title3":"Echinacea Extracts Contain Significant and Selective Activities Against Human Pathogenic Bacteria"},{"title3":"Selection of Natural Health Products for Clinical Trials: a Preclinical Template"},{"title3":"Characterization of antiviral activities in Echinacea root preparations"},{"title3":"Echinacea purpurea aerial parts contain multiple antiviral compounds"},{"title3":"Anti-inflammatory activities of Echinacea extracts do not correlate with traditional marker components"},{"title3":"Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa"},{"title3":"Oseltamivir-Resistant Novel Influenza A (H1N1) Virus Infection in Two Immunosuppressed Patients-Seattle Washington"},{"title3":"Echinacea species (Echinacea angustifolia (DC.) Hell. Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench: a review of their chemistry, pharmacology and clinical properties"}]}]},{"title1":"Randomised, Double Blind, Placebo-Controlled Trial of <italic>Echinacea</italic> Supplementation in Air Travellers","References":[{"title2":"Medical issues associated with commercial flights","References":[{"title3":"Transmission of infectious diseases during commercial air travel"},{"title3":"Oxygen supplementation for chronic obstructive pulmonary disease patients during air travel"},{"title3":"Long- and short-haul travel by air: issues for people with diabetes on insulin"},{"title3":"Cabin cruising altitudes for regular transport aircraft"},{"title3":"Effect of hypobaric hypoxia, simulating conditions during long-haul air travel, on coagulation, fibrinolysis, platelet function, and endothelial activation"},{"title3":"Responding to medical events during commercial airline flights"},{"title3":"Effect of aircraft-cabin altitude on passenger discomfort"},{"title3":"The effect of high altitude commercial air travel on oxygen saturation"},{"title3":"Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations"},{"title3":"Medical Guidelines for Airline Travel, 2nd edn"},{"title3":"Is air travel safe for those with lung disease?"},{"title3":"Hypoxia altitude simulation test"},{"title3":"Hypoxemia during air travel in patients with chronic obstructive pulmonary disease"},{"title3":"The preflight evaluation. A comparison of the hypoxia inhalation test with hypobaric exposure"},{"title3":"Hypoxaemia in chronic obstructive pulmonary disease patients during a commercial flight"},{"title3":"Flight assessment in patients with respiratory disease: hypoxic challenge testing vs predictive equations"},{"title3":"Pulse oximetry in the preflight evaluation of patients with chronic obstructive pulmonary disease"},{"title3":"Using laboratory measurements to predict in-flight desaturation in respiratory patients: are current guidelines appropriate?"},{"title3":"Effects of simulated altitude-induced hypoxia on exercise capacity in patients with chronic heart failure"},{"title3":"Effects of exposure to altitude on men with coronary artery disease and impaired left ventricular function"},{"title3":"Use of certain portable oxygen concentrator devices onboard aircraft. FAA-2004-18596; SFAR No 106"},{"title3":"Final rule"},{"title3":"Modeling targeted layered containment of an influenza pandemic in the United States"},{"title3":"Perforation of a hiatal hernia after a high altitude flight"},{"title3":"Care in the air"},{"title3":"Medical advice for commercial air travelers"},{"title3":"Travel as a risk factor for venous thromboembolic disease: a case-control study"},{"title3":"Long-haul flights and deep vein thrombosis: a significant risk only when additional factors are also present"},{"title3":"Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives"},{"title3":"Travel, venous thromboembolism, and thrombophilia"},{"title3":"Air travel and the risk of deep vein thrombosis"},{"title3":"Travel-related venous thrombosis: results from a large population-based case control study (MEGA study)"},{"title3":"The absolute risk of venous thrombosis after air travel: a cohort study of 8,755 employees of international organisations"},{"title3":"Venous thrombosis after long-haul flights"},{"title3":"Recent air travel and venous thromboembolism resulting in hospital admission"},{"title3":"Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study"},{"title3":"The BEST study-a prospective study to compare business class versus economy class air travel as a cause of thrombosis"},{"title3":"Air travel and venous thromboembolism: a systematic review"},{"title3":"Association between long travel and venous thromboembolic disease: a systematic review and meta-analysis of case-control studies"},{"title3":"Venous thromboembolic complications following air travel: what's the quantitative risk? A literature review"},{"title3":"Travel and venous thrombosis: a systematic review"},{"title3":"Review of venous thromboembolism associated with air travel"},{"title3":"Venous thrombosis from air travel: the LONFLIT3 study:prevention with aspirin vs low-molecular-weight heparin (LMWH) in high-risk subjects: a randomized trial"},{"title3":"Prevention of edema, flight microangiopathy and venous thrombosis in long flights with elastic stockings. A randomized trial: The LONFLIT 4 Concorde Edema-SSL Study"},{"title3":"Severe pulmonary embolism associated with air travel"},{"title3":"Association between acute hypobaric hypoxia and activation of coagulation in human beings"},{"title3":"Economy class syndrome: rheology, fluid balance, and lower leg edema during a simulated 12-hour long distance flight"},{"title3":"Jet leg, pulmonary embolism, and hypoxia"},{"title3":"Changes of biochemical markers and functional tests for clot formation during long-haul flights"},{"title3":"Activation of coagulation system during air travel: a crossover study"},{"title3":"Graduated compression stockings as prophylaxis for flight-related venous thrombosis: systematic literature review"},{"title3":"Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edn)"},{"title3":"Compression stockings for preventing deep vein thrombosis in airline passengers"},{"title3":"Use of preventive measures for air travel-related venous thrombosis in professionals who attend medical conferences"},{"title3":"Aspirin and other antiplatelet drugs in the prevention of venous thromboembolism"},{"title3":"Air travel and thrombosis"},{"title3":"Evaluation and management of the cardiovascular patient embarking on air travel"},{"title3":"Cosmic radiation and commercial air travel"},{"title3":"In-flight radiation exposure during pregnancy"},{"title3":"Galactic cosmic radiation exposure and associated health risks for air carrier crewmembers"},{"title3":"Health physics concerns in commercial aviation"},{"title3":"Occupational cancer risk in pilots and flight attendants: current epidemiological knowledge"},{"title3":"P103: the 2007 Recommendations of the International Commission on Radiological Protection"},{"title3":"Solar radiation alert system. Federal Aviation Administration, US Department of Transportation, 2005, Washington, DC"},{"title3":"Risk of breast cancer in female flight attendants: a population-based study (Iceland)"},{"title3":"Cancer incidence in California flight attendants (United States)"},{"title3":"Breast cancer risk in airline cabin attendants: a nested case-control study in Iceland"},{"title3":"Breast cancer risk among Finnish cabin attendants: a nested case-control study"},{"title3":"Estimated neutron dose to embryo and foetus during commercial flight"},{"title3":"Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report"},{"title3":"Jet lag: trends and coping strategies"},{"title3":"Jet lag: therapeutic use of melatonin and possible application of melatonin analogs"},{"title3":"A retinohypothalamic pathway in man: light mediation of circadian rhythms"},{"title3":"The hypothalamic integrator for circadian rhythms"},{"title3":"Melatonin receptors: role on sleep and circadian rhythm regulation"},{"title3":"Phototransduction by retinal ganglion cells that set the circadian clock"},{"title3":"Intrinsic near-24-h pacemaker period determines limits of circadian entrainment to a weak synchronizer in humans"},{"title3":"Phase shifting two coupled circadian pacemakers: implications for jet lag"},{"title3":"Adapting to phase shifts I. An experimental model for jet lag and shift work"},{"title3":"How to trick mother nature into letting you fly around or stay up all night"},{"title3":"Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review"},{"title3":"Melatonin for preventing and treating jet lag"},{"title3":"Effects of temazepam on sleep, performance, and rhythmic 6-sulphatoxymelatonin and cortisol excretion after transmeridian travel"},{"title3":"Effect of low-dose temazepam on physiological variables and performance tests following a westerly flight across five time zones"},{"title3":"Evaluation of pharmacological aids on physical performance after a transmeridian flight"},{"title3":"Advancing human circadian rhythms with afternoon melatonin and morning intermittent bright light"},{"title3":"Melatonin shifts human circadian rhythms according to a phase-response curve"},{"title3":"Melatonin as a chronobiotic"},{"title3":"Field trial of timed bright light exposure for jet lag among airline cabin crew"},{"title3":"Preflight adjustment to eastward travel: 3 days of advancing sleep with and without morning bright light"},{"title3":"Light visor treatment for jet lag after westward travel across six time zones"},{"title3":"An outbreak of influenza aboard a commercial airliner"},{"title3":"Outbreak of influenza-like illness [corrected] related to air travel"},{"title3":"Low risk of measles transmission after exposure on an international airline flight"},{"title3":"Transmission of the severe acute respiratory syndrome on aircraft"},{"title3":"A case of in-flight transmission of severe acute respiratory syndrome (SARS): SARS serology positive"},{"title3":"Exposure to Mycobacterium tuberculosis during air travel"},{"title3":"Exposure of passengers and flight crew to Mycobacterium tuberculosis on commercial aircraft, 1992-1995"},{"title3":"Salmonellosis outbreak on transatlantic flights; foodborne illness on aircraft: 1947-1984"},{"title3":"Food-poisoning and commercial air travel"},{"title3":"Probable transmission of norovirus on an airplane"},{"title3":"International notes-smallpox-Stockholm"},{"title3":"Aircraft cabin air recirculation and symptoms of the common cold"},{"title3":"Spectrum of viruses and atypical bacteria in intercontinental air travelers with symptoms of acute respiratory infection"},{"title3":"Mitigation strategies for pandemic influenza in the United States"},{"title3":"Delaying the international spread of pandemic influenza"},{"title3":"Empirical evidence for the effect of airline travel on inter-regional influenza spread in the United States"},{"title3":"Commercial aviation in-flight emergencies and the physician"},{"title3":"Cabin fever"},{"title3":"An evaluation of in-flight medical care in the U.S"},{"title3":"Emergency medical kit for commercial airlines: an update"},{"title3":"Airline passenger misconduct: management implications for physicians"},{"title3":"&quot;Is there a doctor on the aircraft?&quot; Top 10 in-flight medical emergencies"},{"title3":"Preflight medical clearance of ill and incapacitated passengers: 3-year retrospective study of experience with a European airline"},{"title3":"Long-distance air travel soon after an acute coronary syndrome: a prospective evaluation of a triage protocol"},{"title3":"International travel and health. Situation as of 1 January 2005. Geneva, 2005"},{"title3":"Safety of air travel following acute myocardial infarction"},{"title3":"Medical Manual 1st ed. International Air Transport Association, Montreal, Canada"},{"title3":"International aeromedical evacuation"},{"title3":"Health and perception of cabin air quality among Swedish commercial airline crew"},{"title3":"Pandemic influenza: a note on international planning to reduce the risk from air transport"},{"title3":"Guidelines for states concerning the management of communicable disease posing a serious public health risk. International Civil Aviation Orgaization, Montreal Canada"}]},{"title2":"Changes in ocular and nasal signs and symptons among air crew in relation to air humidification on intercontinental flights","References":[]},{"title2":"Allergic rhinitis and ear pain in flight","References":[]},{"title2":"Spectrum of viruses and atypical bacteria in intercontinental air travelers with symptoms of acute respiratory infection","References":[{"title3":"Respiratory infections during air travel"},{"title3":"Aircraft cabin air recirculation and symptoms of the common cold"},{"title3":"Prevalence of respiratory symptoms among female flight attendants and teachers"},{"title3":"Transmission of infectious diseases during commercial air travel"},{"title3":"Community-acquired pneumonia"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients"},{"title3":"Amplicon sequencing and improved detection of human rhinovirus in respiratory samples"},{"title3":"Cloning of a human parvovirus by molecular screening of respiratory tract samples"},{"title3":"Single-run, parallel detection of DNA from three pneumonia-producing bacteria by real-time polymerase chain reaction"},{"title3":"Evidence of human coronavirus HKU1 and human bocavirus in Australian children"},{"title3":"Detection of human bocavirus in Japanese children with lower respiratory tract infections"},{"title3":"Enhanced identification of viral and atypical bacterial pathogens in lower respiratory tract samples with nucleic acid amplification tests"},{"title3":"Surveillance of respiratory virus infections in adult hospital admissions using rapid methods"},{"title3":"Characterization of viral agents causing acute respiratory infection in a San Francisco University Medical Center Clinic during the influenza season"}]},{"title2":"Risks of travel, benefits of a specialist consult","References":[]},{"title2":"Clinical effects of rhinovirus infections","References":[]},{"title2":"Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease","References":[]},{"title2":"Perception of cabin air quality in airline crew related to air humidification, on intercontinental flights","References":[]},{"title2":"Complementary and alternative medicine use in Australia: a national population-based survey","References":[]},{"title2":"Complementary and alternative medicine use in Canada and the United States","References":[]},{"title2":"ABC of complementary medicine: users and practitioners of complementary medicine","References":[]},{"title2":"Echinacea increases arginase activity and has anti-inflammatory properties in RAW 264.7 macrophage cells, indicative of alternative macrophage activation","References":[{"title3":"Immune stimulants and antiviral botanicals: Echinacea and ginseng"},{"title3":"Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties"},{"title3":"Light-mediated antifungal activity of Echinacea extracts"},{"title3":"Inflammation and Native American medicine: the role of botanicals"},{"title3":"Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway"},{"title3":"The involvement of tyrosine kinases, cyclic AMP/protein kinase A, and p38 mitogen-activated protein kinase in IL-13-mediated arginase I induction in macrophages: its implications in IL-13-inhibited nitric oxide production"},{"title3":"Macrophage activating effects of new alkamides from the roots of Echinacea species"},{"title3":"Cytotoxic activity of polyacetylenes and polyenes isolated from roots of Echinacea pallida"},{"title3":"Determination of arginase activity in macrophages: a micromethod"},{"title3":"Involvement of protein kinase A in the induction of arginase in murine bone marrow-derived macrophages"},{"title3":"Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture"},{"title3":"Synergistic antioxidative effects of alkamides, caffeic acid derivatives, and polysaccharide fractions from Echinacea purpurea on in vitro oxidation of human low-density lipoproteins"},{"title3":"Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system"},{"title3":"Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways"},{"title3":"Arginase II downregulates nitric oxide (NO) production and prevents NO-mediated apoptosis in murine macrophage-derived RAW 264.7 cells"},{"title3":"Studies on the antioxidant activity of Echinacea root extract"},{"title3":"Determination of echinacoside in rat serum by reversed-phase high-performance liquid chromatography with ultraviolet detection and its application to pharmacokinetics and bioavailability"},{"title3":"Inhibition of LPS-induced nitric oxide and TNF-alpha by alpha-lipoic acid in rat Kupffer cells and in RAW 264.7 cells"},{"title3":"The first synthesis of a diynone from Echinacea pallida"},{"title3":"Chlorogenic acid is absorbed in its intact form in the stomach of rats"},{"title3":"Alkamide stability in Echinacea purpurea extracts with and without phenolic acids in dry films and in solution"},{"title3":"Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages"},{"title3":"Nitric oxide and macrophage function"},{"title3":"Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways"},{"title3":"Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion"},{"title3":"Alkylamides from Echinacea modulate induced immune responses in macrophages"},{"title3":"Permeability studies of alkylamides and caffeic acid conjugates from Echinacea using a Caco-2 cell monolayer model"},{"title3":"Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness"},{"title3":"Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines"},{"title3":"Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells"},{"title3":"Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype"},{"title3":"Anti-inflammatory activity of herbal medicines: inhibition of nitric oxide production and tumor necrosis factor-alpha secretion in an activated macrophage-like cell line"},{"title3":"Analysis of phenolic compounds and radical scavenging activity of Echinacea spp"},{"title3":"Use of Echinacea in medicine"},{"title3":"Macrophage activation switching: an asset for the resolution of inflammation"},{"title3":"Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects"},{"title3":"Investigation of anti-hyaluronidase treatment on vocal fold wound healing"},{"title3":"Echinacea extracts modulate the production of multiple transcription factors in uninfected cells and rhinovirus-infected cells"},{"title3":"Anti-inflammatory and cicatrizing activity of Echinacea pallida Nutt. root extract"},{"title3":"Nitric oxide scavenging by curcuminoids"},{"title3":"Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation"},{"title3":"The fate of trans-caftaric acid administered into the rat stomach"},{"title3":"Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide"},{"title3":"Induction of arginase II in human Caco-2 tumor cells by cyclic AMP"},{"title3":"The role of alkamides as an active principle of Echinacea"},{"title3":"Bioavailability and pharmacokinetics of alkamides from the roots of Echinacea angustifolia in humans"},{"title3":"The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots"},{"title3":"Nitric oxide modulates pro- and anti-inflammatory cytokines in lipopolysaccharide-activated macrophages"},{"title3":"Diacetylenic isobutylamides of Echinacea: synthesis and natural distribution"},{"title3":"Increased production of nitric oxide stimulated by interleukin-1beta in peripheral blood mononuclear cells in patients with systemic sclerosis"},{"title3":"Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer"},{"title3":"Alcohol extracts of Echinacea inhibit production of nitric oxide and tumor necrosis factor-alpha by macrophages in vitro"},{"title3":"Enhancement of innate and adaptive immune functions by multiple Echinacea species"}]},{"title2":"Echinacea as an antiinflammatory agent: the influence of physiologically relevant parameters","References":[]},{"title2":"Antiviral activity of characterized extracts from Echinacea spp. (Heliantheae: Asteraceae) against Herpes simplex virus (HSV-I)","References":[]},{"title2":"Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract","References":[]},{"title2":"Enhancement of innate and adaptive immune functions by multiple Echinacea species","References":[]},{"title2":"Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects","References":[]},{"title2":"Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis","References":[{"title3":"The common cold, health matters fact sheets"},{"title3":"The common cold"},{"title3":"Evaluation of echinacea for treatment of the common cold"},{"title3":"Treatment of the common cold with echinacea: a structured review"},{"title3":"The safety of herbal medicinal products derived from Echinacea species"},{"title3":"The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots"},{"title3":"Echinacea angustifolia: natural health products directorate. Draft January, 2004"},{"title3":"Echinacea purpurea: natural health products directorate. Draft January 19, 2004"},{"title3":"Echinacea pallida: natural health products directorate. Draft January 19, 2004"},{"title3":"Echinacea for preventing and treating the common cold"},{"title3":"An evaluation of Echinacea angustifolia in experimental rhinovirus infections"},{"title3":"Echinacea root extract for the prevention of upper respiratory tract infections: A double-blind, placebo-controlled randomized trial"},{"title3":"Therapeutic experiences with Echinacea pallida in influenzal infections"},{"title3":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?"},{"title3":"Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events"},{"title3":"Treatment of the common cold with unrefined echinacea. A randomized, double-blind, placebo controlled trial"},{"title3":"Echinacea and truth in labeling"},{"title3":"Echinacea purpurea for prevention of experimental rhinovirus colds"},{"title3":"Efficacy of Echinacea purpurea in patients with a common cold: a placebo-controlled, randomised, double-blind clinical trial"},{"title3":"A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections"},{"title3":"Influence of echinacin (EC31) treatment on the exercise-induced immune response in athletes"},{"title3":"Echinaguard treatment shortens the course of the common cold: a double-blind, placebo-controlled clinical trial"},{"title3":"Effectiveness of an herbal preparation containing echinacea, propolis and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study"},{"title3":"The efficacy of echinacea compound herbal tea preparation on the severity and duration of upper respiratory and flu symptoms: a randomized, double-blind placebo-controlled study"},{"title3":"Efficacy in the treatment of the common cold of a preparation containing an echinacea extract"},{"title3":"Ineffectiveness of echinacea for prevention of experimental rhinovirus colds"},{"title3":"Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial"},{"title3":"Use of echinacea in upper respiratory tract infection"},{"title3":"Vitamin C supplementation and respiratory infections: a systematic review"},{"title3":"Review of the biological properties and toxicity of bee propolis"},{"title3":"Echinacea angustifolia in rhinovirus infections"},{"title3":"Echinacea for preventing and treating the common cold"},{"title3":"Echinacea for the common cold"},{"title3":"An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures"}]},{"title2":"Echinacea for preventing and treating the common cold","References":[{"title3":"Medicinal properties of Echinacea: a critical review"},{"title3":"Echinacea for preventing and treating the common cold"},{"title3":"Cough and the common cold: ACCP evidence-based clinical practice guidelines"},{"title3":"Treatment guidelines for upper respiratory tract infections"},{"title3":"Clinical knowledge summaries: common cold"}]},{"title2":"Echinacea for preventing and treating the common cold","References":[{"title3":"Medicinal properties of Echinacea: a critical review"},{"title3":"Echinacea for preventing and treating the common cold"},{"title3":"Cough and the common cold: ACCP evidence-based clinical practice guidelines"},{"title3":"Treatment guidelines for upper respiratory tract infections"},{"title3":"Clinical knowledge summaries: common cold"}]},{"title2":"Echinacea for treating the common cold a randomized trial","References":[{"title3":"Virology and immunology of the common cold"},{"title3":"Viral respiratory infections in the community: Epidemiology, agents, and interventions"},{"title3":"Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children"},{"title3":"Time lines of infection and disease in human influenza: a review of volunteer challenge studies"},{"title3":"Does this patient have influenza?"},{"title3":"Understanding the symptoms of the common cold and influenza"},{"title3":"Influenza"},{"title3":"The economic burden of non-influenza-related viral respiratory tract infection in the United States"},{"title3":"New considerations in the treatment and prevention of rhinovirus infections"},{"title3":"From Rudbeckia to Echinacea: The emergence of the purple cone flower in modern therapeutics"},{"title3":"Echinacea species as potential immunostimulatory drugs"},{"title3":"Immunomodulation with Echinacea - a systematic review of controlled trials"},{"title3":"Medicinal properties of Echinacea: A critical review"},{"title3":"Echinacea and ginseng for immunomodulation and protection from respiratory infection"},{"title3":"Chemistry, analysis and immunological investigations of Echinacea phytopharmaceuticals"},{"title3":"Immune system effects of echinacea, ginseng, and astragalus: a review"},{"title3":"Immunomodulating activity of Echinacea gloriosa L., Echinacea angustifolia DC., and Rudbeckia speciosa Wenderoth ethanol-water extracts"},{"title3":"Alkylamides of Echinacea purpurea stimulate alveolar macrophage function in normal rats"},{"title3":"Pharmacokinetics and immunomodulatory effects of phytotherapeutic lozenges (bonbons) with Echinacea purpurea extract"},{"title3":"Immunologically active polysaccharides of Echinacea purpurea cell cultures"},{"title3":"The role of alkamides as an active principle of echinacea"},{"title3":"Alcohol extracts of Echinacea inhibit production of nitric oxide and tumor necrosis factor-alpha by macrophages in vitro"},{"title3":"The oxidative burst of HL-60 cells is modified differently by individual echinacea species and plant parts"},{"title3":"The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo"},{"title3":"Transport of alkamides from Echinacea species through Caco-2 monolayers"},{"title3":"Cytochrome P450 enzyme-mediated degradation of Echinacea alkylamides in human liver microsomes"},{"title3":"The endocannabinoid system as a target for alkamides from Echinacea angustifolia roots"},{"title3":"Bioavailability and pharmacokinetics of Echinacea purpurea preparations and their interaction with the immune system"},{"title3":"Changes in immunomodulatory properties of Echinacea spp. root infusions and tinctures stored at 4 degrees C for four days"},{"title3":"Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways"},{"title3":"Alkamides from Echinacea inhibit cyclooxygenase-2 activity in human neuroglioma cells"},{"title3":"Echinacea species and alkamides inhibit prostaglandin E(2) production in RAW264.7 mouse macrophage cells"},{"title3":"Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion"},{"title3":"Pharmacokinetics of the main alkamides after administration of three different Echinacea purpurea preparations in humans"},{"title3":"The role of alkamides as an active principle of echinacea"},{"title3":"Alcohol extracts of Echinacea inhibit production of nitric oxide and tumor necrosis factor-alpha by macrophages in vitro"},{"title3":"Echinacea for upper respiratory infection: Evidence-based clinical review"},{"title3":"Evaluation of Echinacea for treatment of the common cold"},{"title3":"Treatment of the common cold with unrefined echinacea: A randomized, double-blind, placebo-controlled trial"},{"title3":"Effectiveness of an herbal preparation containing Echinacea, Propolis, and Vitamin C in preventing respiratory tract infections in children: A randomized, double-blind, placebo-controlled, multicenter study"},{"title3":"Efficacy of a standardized echinacea preparation (Echinilin) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trial"},{"title3":"Echinacea purpurea for prevention of experimental rhinovirus colds"},{"title3":"Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial"},{"title3":"Ineffectiveness of Echinacea for prevention of experimental rhinovirus colds"},{"title3":". An evaluation of Echinacea angustifolia in experimental rhinovirus infections"},{"title3":"Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial"},{"title3":"Treatment of the common cold with echinacea: a structured review"},{"title3":"The safety of herbal medicinal products derived from echinacea species: a systematic review"},{"title3":"Echinacea for preventing and treating the common cold"},{"title3":"Echinacea in the prevention of induced Rhinovirus colds"},{"title3":"Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis"},{"title3":"Rationale and methods for a trial assessing placebo, echinacea, and doctor-patient interaction in the common cold"},{"title3":"Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, Interleukin-1, and Interleukin-6"},{"title3":"Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection"},{"title3":"Nasal cytokine production in viral acute upper respiratory infection of childhood"},{"title3":"Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus induced asthma"},{"title3":"Present concepts of the common cold"},{"title3":"The Wisconsin Upper Respiratory Symptom Survey is responsive, reliable, and valid"},{"title3":"Validation of a short form Wisconsin Upper Respiratory Symptom Survey (WURSS-21)"},{"title3":"Types of stressors that increase susceptibility to the common cold in healthy adults"},{"title3":"A global measure of perceived stress"},{"title3":"Perceived stress in a probability sample of the United States"},{"title3":"Psychological well-being: Meaning, measurement, and implications for psychotherapy research"},{"title3":"Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): A re-evaluation of the Life Orientation Test"},{"title3":"A test of missing completely at random for multivariate data with missing values"},{"title3":"Using benefit harm tradeoffs to estimate sufficiently important difference: the case of the common cold"},{"title3":"Sufficiently important difference for common cold: severity reduction"},{"title3":"Comparison of anchor-based and distributional approaches in estimating important difference in common cold"}]},{"title2":"Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties","References":[]},{"title2":"Echinacea intake induces an immune response through altered expression of leucocyte hsp70, increased white cell counts and improved erythrocyte antioxidant defences","References":[]},{"title2":"Pharmacokinetics of the main alkamides after administration of three different Echinacea purpurea preparations in humans","References":[]},{"title2":"Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestion","References":[]},{"title2":"Echinacea alkylamides inhibit interleukin-2 production by Jurkat T cells","References":[]},{"title2":"A standardized echinacea extract demonstrates efficacy in the prevention and treatment of colds in athletes","References":[]},{"title2":"Echinacea in the prevention of induced rhinovirus colds: a meta-analysis","References":[]},{"title2":"Echinacea for prevention of the common cold: an illustrative overview of how information from different systematic reviews is summarised on the internet","References":[]},{"title2":"Comparison of Echinacea alkylamide pharmacokinetics between liquid and tablet preparations","References":[]},{"title2":"The Wisconsin Upper Respiratory symptom survey (WURSS): a new research instrument for assessing the common cold","References":[]},{"title2":"The Wisconsin Upper Respiratory Symptom Survey is responsive, reliable, and valid","References":[{"title3":"Respiratory tract infections as a public health challenge"},{"title3":"Rhinovirus infections in an industrial population"},{"title3":"Acute respiratory illness in an American community: the Tecumseh study"},{"title3":"The economic burden of non-influenza-related viral respiratory tract infection in the United States"},{"title3":"Over-the-counter cold medications: a critical review of clinical trials between 1950 and 1991"},{"title3":"The treatment of rhinovirus infections: progress and potential"},{"title3":"Susceptibility and immunity to common upper respiratory viral infections: the common cold"},{"title3":"Acute respiratory diseases of viral etiology. VII. Present concepts of the common cold"},{"title3":"Rhinovirus colds: epidemiology, clinical characteristics and transmission"},{"title3":"The Wisconsin Upper Respiratory Symptom Survey (WURSS): a new research instrument for assessing the common cold"},{"title3":"Determining a minimal important change in a disease-specific Quality of Life Questionnaire"},{"title3":"Measuring disease-specific quality of life in clinical trials"},{"title3":"Measuring change over time: Assessing the usefulness of evaluative instruments"},{"title3":"How should the minimum important difference for a health-related quality-of-life instrument be estimated?"},{"title3":"Minimal clinically important difference module: summary, recommendations, and research agenda"},{"title3":"The minimal important difference: who's to say what is important?"},{"title3":"Measurement of health status: ascertaining the minimal clinically important difference"},{"title3":"Assessing the minimal important difference in symptoms: a comparison of two techniques"},{"title3":"Clinical Significance Consensus Meeting Group. Methods to explain the clinical significance of health status measures"},{"title3":"Methodological issues in the search for a factor model: exploration through confirmation"},{"title3":"Statistical analysis of sets of congeneric tests"},{"title3":"Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children"},{"title3":"Frequency and history of rhinovirus infections in adults during autumn"},{"title3":"Virology and immunology of the common cold"},{"title3":"Epidemiology, pathogenesis, and treatment of the common cold"},{"title3":"The influence of signal variation, bias, noise and effect size on statistical significance in treatment studies of the common cold"},{"title3":"Medicine's symbolic reality: on a central problem in the philosophy of medicine"}]},{"title2":"Relations among questionnaire and laboratory measures of rhinovirus infection","References":[]},{"title2":"How should the minimum important difference for a health-related quality-of-life instrument be estimated?","References":[]},{"title2":"Air travel and respiratory disease: proper assessment and preparation reduce the risk, but it pays to shop around","References":[]},{"title2":"Respiratory infections during air travel","References":[{"title3":"Impact of travel-related health impairments"},{"title3":"Fever in returned travelers: review of hospital admissions for a 3-year period"},{"title3":"Aircraft cabin air recirculation and symptoms of the common cold"},{"title3":"Transmission of the severe acute respiratory syndrome on aircraft"},{"title3":"Cabin air quality: an overview"},{"title3":"Air quality on long flights"},{"title3":"Health issues of air travel"},{"title3":"Concentrations of selected contaminants in cabin air of airbus aircrafts"},{"title3":"The microbiological composition of airliner cabin air"},{"title3":"Dissemination of human pathogens by airline travel"},{"title3":"The possible effects on health, comfort and safety of aircraft cabin environments"},{"title3":"Comfort and health in commercial aircraft: a literature review"},{"title3":"Trains, travel, and the tubercle"},{"title3":"Impact of influenza vaccination on civilian aircrew illness and absenteeism"},{"title3":"An outbreak of influenza aboard a commercial airliner"},{"title3":"An outbreak of influenza A/Taiwan/1/86 (H1N1) infections at a naval base and its association with airplane travel"},{"title3":"Influenza outbreak related to air travel"},{"title3":"A train passenger with pulmonary tuberculosis: evidence of limited transmission during travel"},{"title3":"Exposure of passengers and flight crew to Mycobacterium tuberculosis on commercial aircraft, 1992-1995"},{"title3":"Transmission of multidrug-resistant Mycobacterium tuberculosis during a long airplane flight"},{"title3":"Transmission of Mycobacterium tuberculosis associated with air travel"},{"title3":"Two-step tuberculin testing of passengers and crew on a commercial airplane"},{"title3":"Tuberculosis risk after exposure on airplanes"},{"title3":"A passenger with pulmonary/laryngeal tuberculosis: no evidence of transmission on two short flights"},{"title3":"A case of infectious tuberculosis on two long-haul aircraft flights: contact investigation"},{"title3":"Exposure to Mycobacterium tuberculosis during air travel"},{"title3":"Tuberculosis on the flight deck"},{"title3":"Confronting the new challenge in travel medicine: SARS"},{"title3":"In-flight transmission of Severe Acute Respiratory Syndrome (SARS): a case report"},{"title3":"SARS and occupational health in the air"},{"title3":"Low risk of transmission of severe acute respiratory syndrome on airplanes: the Singapore experience"},{"title3":"Imported measles in the United States"},{"title3":"Interstate importation of measles following transmission in an airport - California, Washington, 1982"},{"title3":"Disease transmission by aircraft"},{"title3":"Exposure to patients with meningococcal disease on aircrafts - United States, 1999-2001"}]},{"title2":"Lack of herbal supplement characterization in published randomized controlled trials","References":[]},{"title2":"Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: efficacy and safety","References":[]},{"title2":"The effect of Echinacea on upper respiratory infection symptom severity and quality of life","References":[]},{"title2":"The safety of herbal medicinal products derived from Echinacea species: a systematic review","References":[]}]}]}